Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction

This publication has 35 references indexed in Scilit:

• The Sulfonylurea Controversy: More Questions From the Heart 11This study was supported by a Clinician-Investigator Fellowship from General Mills, Rochester, Minnesota; by the American Heart Association, Minnesota Affiliate, Minneapolis; by the Miami Heart Research Institute, Miami, Florida; and by the Bruce and Ruth Rappaport Program in Vascular Biology and Gene Delivery, Geneva, Switzerland.
  Journal of the American College of Cardiology, 1998
• Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
  Journal of the American College of Cardiology, 1997
• Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
  New England Journal of Medicine, 1996
• Sulfonylurea receptors and mechanism of sulfonylurea action
  Experimental and Clinical Endocrinology & Diabetes, 1996
• Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study
  American Heart Journal, 1995
• The Pharmacology of ATP-Sensitive Potassium Channels
  Annual Review of Pharmacology and Toxicology, 1993
• Sulfonylureas in NIDDM
  Diabetes Care, 1992
• Oral Hypoglycemic Agents
  New England Journal of Medicine, 1989
• Myocardial infarction in patients with diabetes mellitus
  European Heart Journal, 1988
• Prevalence and Mortality of Acute Myocardial Infarction in Patients with Diabetes
  Diabetes Care, 1985